Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
about
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly peopleToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseThe clinical use of structural MRI in Alzheimer diseaseBrain fuel metabolism, aging, and Alzheimer's diseasePosterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairmentIn vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBiomarkers of Alzheimer's diseaseChocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET ImagingAre Anxiety Disorders Associated with Accelerated Aging? A Focus on NeuroprogressionHow does it STAC up? Revisiting the scaffolding theory of aging and cognitionPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseBrain PET in the diagnosis of Alzheimer's diseaseDevelopment of positron emission tomography β-amyloid plaque imaging agentsUshering in the study and treatment of preclinical Alzheimer diseaseUltrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse modelsExisting Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation18F-florbetaben Aβ imaging in mild cognitive impairmentThe Eye As a Biomarker for Alzheimer's DiseaseBeta-amyloid deposition and the aging brainApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyValidation of the Face Name Associative Memory Exam in cognitively normal older individualsAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsPET amyloid-beta imaging in preclinical Alzheimer's diseaseBiomarkers for cognitive impairment and dementia in elderly people.In vivo assessment of amyloid-β deposition in nondemented very elderly subjectsClassification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.What have novel imaging techniques revealed about metabolism in the aging brain?Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Brain imaging in dementia.APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Imaging in Alzheimer's disease.Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's diseasePittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseNormal cognitive aging.
P2860
Q22253051-4797FFB3-C1A3-45F0-8ED4-34E1914B36FCQ24595802-BE627E5F-765D-45A1-9953-2E94C9C4E978Q24609648-7C6E9E63-790C-4C7E-8146-1B0EE209F205Q24625859-5148B7B3-BBF8-40FA-8971-7AD8FC5F01EFQ24630245-F4B4FB3F-CC45-4E4F-989F-C53B3370405CQ24630918-A9C10A62-929B-4C3D-87BB-674905B249CCQ24648319-1AF75CDD-7DA6-45FB-8E2A-E782AEF9E659Q24650667-4EF96957-401E-4162-BA52-488595E44FCAQ26738827-8BAC16F7-3DDF-4302-9176-D043FA39555EQ26750249-A0A482F6-6948-4A53-B009-FDF94314EF99Q26765559-16D12F7A-4A06-44BC-8E26-6CE5F5BA7DA1Q26827532-98DD524B-9C48-4C87-9500-3D9791B786F6Q26995405-88201D6C-D2A2-4627-A2B6-0443175FB3A0Q27008249-A1A53B2B-832D-478A-8EA8-D75E8344F639Q27009411-AF5B67B6-06F8-4E61-9B4E-FA4C1BD70D9DQ27011549-5AF98AA2-3E84-47B2-BC2D-37D9691A63B9Q27012742-961C2556-31D4-4021-89BC-E26FFAF253BFQ27014791-C0CCA7D6-C64A-4C56-B97B-C85EE41BA641Q27301343-BD9DA631-F74B-4315-B5ED-0B9DC0B6725AQ27303745-917CC116-ABD7-49E5-90B1-90205284E489Q27499311-72EFF533-4006-496B-85B7-848415BE3304Q28070142-73567B04-B438-4A37-914E-0D80482D779CQ28264556-22ED8A85-FB32-45F7-A2E5-7545224611AAQ28282855-11C08398-3C82-48F8-83FF-3F357E233BA0Q28386196-3C380344-D086-405D-AE8A-1BF88CA343A1Q28488143-8409778B-D550-40EA-BD57-ADEF65464CB3Q30040695-4FAB3840-5067-478C-BE51-A608209A5153Q30370745-6E8E56D5-062D-4BC7-BAAD-D2D423BF7349Q30412704-E1D99CF8-5C42-45E7-A3CB-ADBE5170BA91Q30413572-2F08E7B8-B037-4E10-83DD-8C55C11014C3Q30426091-5ECD0B9C-6BE1-494E-A1A1-153C1E12DCCAQ30492809-3DB97464-43E0-4798-980C-0B8DC14EE4CEQ30850844-52DAF447-2DFA-4E61-AC60-57CC20763915Q30996799-81FE5B7B-F613-4CDD-8A8C-E92A6A67CCCAQ31051218-BFDD3224-3841-4825-BEC2-E63EA7A5C97BQ33423191-8552D695-6D8A-4443-91C7-9745C3E9EFA5Q33479675-076D93A3-AACA-4DF6-B260-8372104679AEQ33494855-94A00AE0-5B64-4DFF-8F58-BE704DF657FDQ33560183-CAECA992-EC56-4536-BC0C-253555D320DCQ33587391-B681F04B-2BDC-4A9F-9937-4653BC058241
P2860
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@en
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@nl
type
label
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@en
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@nl
prefLabel
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@en
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@nl
P2093
P50
P356
P1433
P1476
Beta-amyloid imaging and memor ...... eclinical Alzheimer's disease.
@en
P2093
Chester A Mathis
Christopher C Rowe
Simon A Moss
Victor L Villemagne
P304
P356
10.1093/BRAIN/AWM238
P407
P577
2007-10-10T00:00:00Z